Wachtell Lipton Rosen & Katz is heading into the year’s final quarter outpacing all other law firms in the dollar value of global mergers and acquisitions on which it’s served as an adviser.
Kirkland & Ellis advised Bristol-Myers Squibb Co. in its all-cash $13.4 billion sale of Celgene Corp.’s psoriasis drug Otezla to Amgen Inc., which is being advised by Sullivan & Cromwell.
Munger,Tolles & Olson partner George Fatheree III recently succeeded in preserving for the public an invaluable visual archive of 20th century black America—and he and his colleagues only had 48 …
Hogan Lovells is representing Russian billionaire Mikhail Prokhorov in his sale of the Barclays Center and controlling interest in the Brooklyn Nets to an entity controlled by Joe Tsai, co-founder …
Skadden Arps, Slate, Meagher & Flom and Simpson, Thacher & Bartlett are helping WeWork go public in one of the most highly anticipated initial public offerings of 2019.
A group of the most prestigious firms in Big Law lined up to advise CBS Corp and Viacom Inc. in their long-awaited all-stock merger that would create a combined company with more than $28 billion in …
Cravath, Swaine & Moore and Wachtell Lipton Rosen & Katz have taken lead roles in Mylan N.V. and Pfizer Inc.’s all-stock tie-up.
Wachtell, Lipton, Rosen & Katz and Kirkland & Ellis have advised on the largest volume of deals in the first half of 2019, in a cycle dominated by “mega deals” worth over $10 billion.
Paul Weiss, Rifkind, Wharton & Garrison is adding private equity specialist Sarah Stasny from Kirkland & Ellis as a partner in its corporate department in New York.
Kirkland & Ellis advised AbbVie Inc. in its $63 billion cash and stock purchase of Botox-maker Allergan Inc., which was represented by Wachtell in one of the largest mergers in the pharmaceutical …